Example: Heart Attack

Clinical Trials on Glabellar Crease

Total 10000 results

NCT04740918

Terminated

A Study of Trastuzumab Emtansine in Combination With Atezolizumab or Placebo as a Treatment for Participants With Human Epidermal Growth Factor 2 (HER2)-Positive and Programmed Death-ligand 1 (PD-L1)-Positive Locally Advanced (LABC) or Metastatic Breast Cancer (MBC) (KATE3)

Metastatic Breast Cancer
NCT04251169

Terminated

Pembrolizumab + Paclitaxel in HR+/HER2- Non-luminal (by PAM50) Advanced Breast Cancer After CDK4/6 Inhibitor Progression (TATEN)

Metastatic Breast Cancer
NCT03333122

Active, not recruiting

Assessment of Breast Cancer Patients Satisfaction and Health Related Quality of Life Outcomes

Breast Cancer Female
NCT04829643

Completed

Axillary Staging in Early Breast Cancer: SNB Vs PET/MRI

Breast Cancer | Sentinel Lymph Node | Early-stage Breast Cancer
NCT06058936

Completed

Exercises Using Virtual Reality on Cancer Patients

Breast Cancer Female
NCT06857305

Enrolling by invitation

Efficacy and Safety of Biweekly Regimen of Eribulin Versus a Standard Regimen for the Treatment of Locally Recurrent or Metastatic HER2-negative Breast Cancer: a Multicenter, Randomized, Open-label, Phase III Trial

Breast Cancer Metastatic
NCT06873997

Completed

Real World Study of Bone Metastases in Patients with Advanced Breast Cancer

Breast Cancer Metastatic
NCT03133988

Approved for marketing

Margetuximab Expanded Access Program

HER2-positive Breast Cancer | HER2-positive Carcinoma
NCT04172220

Completed

Does Type of Anesthesia Influence Inflammation Change After Breast Surgery?

Breast Cancer Female
NCT03409198

Completed

Phase IIb Study Evaluating Immunogenic Chemotherapy Combined with Ipilimumab and Nivolumab in Breast Cancer (ICON)

Breast Cancer | Metastatic Breast Cancer | Hormone Receptor Positive Tumor
NCT06320392

Completed

Implication of CCR4-NOT Complex Subunit 7 Expression in Natural Killer Cell Resistance in Metastatic Breast Cancer (CCR4-NOT)

Metastatic Breast Cancer
NCT05068726

Terminated

Clinical Utility of FES F18 PET/CT in Metastatic Breast Cancer Patients

Metastatic Breast Cancer
NCT04367090

Completed

Pharmacokinetic Study of Pyrotinib and Docetaxel in Combination With Trastuzumab in Patients With HER2 Metastatic Breast Cancer

Metastatic Breast Cancer
NCT04035408

Withdrawn

Facial Skin Health Tracking Feasibility in Breast Cancer Patients

Breast Cancer Female
NCT03709186

Completed

Radiomic Markers for Breast Cancer Metastasis and Treatment Response Using MRI

Invasive Breast Cancer
NCT03210974

Completed

Retrospective Observational Study About Evolution of Patients With Breast Cancer in Hospitals From GEICAM Group (ALAMO-IV)

Invasive Breast Cancer Between 2002 and 2005
NCT01920061

Completed

A Study Of PF-05212384 In Combination With Other Anti-Tumor Agents and in Combination With Cisplatin in Patients With Triple Negative Breast Cancer in an Expansion Arm (TNBC)

Neoplasm
NCT02963740

Completed

Feasibility of High Levels of Energy Expenditure From Physical Activity for Breast Cancer Survivors

Breast Cancer Female
NCT02418689

Completed

Poziotinib in Patients With HER2+ Recurrent Stage IV BC Who Have Received at Least 2 Prior HER2-directed Regimens

Metastatic Breast Cancer
NCT05108740

No longer available

MAP Treatment Plan With Afinitor for Postmenopausal Women With Advanced HR+ Breast Cancer

Advanced Hormone Receptor Positive (HR+) Breast Cancer
NCT02536339

Completed

A Study of Pertuzumab With High-Dose Trastuzumab for the Treatment of Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer (MBC) With Central Nervous System (CNS) Progression Post-Radiotherapy

Metastatic Breast Cancer
NCT03139851

Completed

Evaluation of Pembrolizumab in Lymphopenic Metastatic Breast Cancer Patients Treated With Metronomic Cyclophosphamide (CHEMOIMMUNE)

Metastatic Breast Cancer
NCT04300283

Completed

Pre-operative Hypnosis to Prevent Side Effects After Surgery (PREVENTpilot)

Breast Cancer Surgery
NCT03966898

Active, not recruiting

A Study of SHR6390 in Combination With Letrozole or Anastrozole in Patients With HR Positive and HER2 Negative Advanced Breast Cancer

Advanced Breast Cancer
NCT03161834

Withdrawn

Plasma Circulating Tumor DNA Analyses in ER+ Metastatic Breast Cancer

Metastatic Breast Cancer
NCT00570258

Terminated

Randomized, Double Blind Multicenter Phase II Study of Time to Progression on Fulvestrant in Combination With Erlotinib or Placebo in Hormone Receptor-Positive Metastatic Breast Cancer (MBC) Subjects Who Progressed on First Line Hormonal Therapy

Metastatic Breast Cancer
NCT00461773

Terminated

Randomized Phase II Study of Preoperative Letrozole (Femara) in Combination With Avastin in Hormone Receptor Positive Breast Cancer

Breast Cancer | Hormone-Sensitive Breast Cancer
NCT02626013

Completed

Real-world Evidence Prospective Study on the Effect of Nab-paclitaxel Treatment on the Clinical Outcomes and HRQoL in Patients With MBC in Greece (ABReast)

Metastatic Breast Cancer
NCT02626039

Completed

Characterization & Comparison of Drugable Mutations in Primary and Metastatic Tumors, CTCs and cfDNA in MBCpatients (MIRROR)

Metastatic Breast Cancer
NCT02344550

Completed

Study of GnRH-A [Leuprorelin(Lorelin Depot] Plus Leterozole +/- Everolimus for Premenopausal Women With Metastatic Breast Cancer (LEO)

Metastatic Breast Cancer
NCT02058381

Completed

A Phase Ib Dose De-escalation Study With BYL719 in Premenopausal Patients With Locally Advanced or Metastatic Breast Cancer (B-YOND)

Pre-menopausal Breast Cancer | PI3K Pathway Inhibition
NCT02844335

Completed

Combination of Cryosurgery and NK Immunotherapy for Advanced Breast Cancer

Breast Cancer Recurrent
NCT02983604

Terminated

GS-5829 in Combination With Fulvestrant or Exemestane in Women With Advanced Estrogen Receptor Positive, HER2 Negative-Breast Cancer

Advanced Estrogen Receptor Positive HER2- Breast Cancer
NCT01792726

Unknown

A Comparison of Intra-operative Radiotherapy Boost With External Beam Radiotherapy Boost in Early Breast Cancer. (TARGIT-B)

Early Breast Cancer
NCT01326481

Completed

Open Label Dose-Finding Study of TRC105 Plus Capecitabine for Metastatic Breast Cancer (TRC105)

Metastatic Breast Cancer
NCT01837095

Completed

Dose Escalation of POL6326 in Combination With Eribulin in Patients With Metastatic Breast Cancer

Metastatic Breast Cancer
NCT00445458

Completed

A Phase 1/2 Study of HKI-272 (Neratinib) in Combination With Paclitaxel (Taxol) in Subjects With Solid Tumors and Breast Cancer

Breast Neoplasms | Advanced Breast Cancer | Advanced Malignant Solid Tumors
NCT01937507

Terminated

Hepatic Artery Infusion With FOLFOX in Liver Metastasis From Breast Cancer

Metastatic Breast Cancer
NCT00561119

Completed

Maintenance Versus Observation After 6 Cycles of Gemcitabine Plus Paclitaxel in Pts With Advanced Breast Cancer

Advanced Breast Cancer
NCT01283789

Unknown

Lapatinib and RAD-001 for HER2 Positive Metastatic Breast Cancer

Metastatic Breast Cancer
NCT00694252

Completed

Lapatinib and Circulating Tumor Cells in Breast Cancer

Metastatic Breast Cancer
NCT01334099

Terminated

Safety Study of Radiation and CP-675,206 Infusion for Breast Cancer Patients

Metastatic Breast Cancer
NCT02111031

Withdrawn

Clinical Utility of CTC Test in Medicare-Eligible Metastatic Breast Cancer Patients

Breast Cancer | Metastatic Breast Cancer
NCT00044525

Completed

Evaluation of BAY59-8862 in Taxane-Resistant Metastatic Breast Cancer Patients

Breast Neoplasms | Breast Cancer, Metastatic
NCT01309607

Unknown

Study of Preoperative Weekly Paclitaxel and Carboplatin With Lapatinib (Tykerb®) in Patients With ErbB2-Positive Stage I-III Breast Cancer

ErbB2-Positive Stage I-III Breast Cancer
NCT01392586

Terminated

Systemic Therapy With or Without Upfront Surgery in Metastatic Breast Cancer (SUBMIT)

Metastatic Breast Cancer
NCT00811369

Completed

Trial to Evaluate the Therapeutic Benefit of Fulvestrant in Combination With ZACTIMA in Postmenopausal Women With Bone Predominant, Hormone Receptor Positive Metastatic Breast Cancer (ZAMBONEY)

Metastatic Breast Cancer
NCT01715155

Completed

Management of Metastatic Breast Cancer in Clinical Practice - Retrospective Study

Metastatic Breast Cancer
NCT00645177

Completed

Phase 2 Study of ABT-869 in Combination With Paclitaxel Versus Paclitaxel Alone to Treat Metastatic Breast Cancer

Metastatic Breast Cancer
NCT01282931

Completed

Patient-reported Outcome Questionnaire for Women With Metastatic Breast Cancer

Metastatic Breast Cancer

Clinical Trials on Glabellar Crease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations